Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive source : Www.aquestive.com save search
Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies for AQST-109 Epinephrine Sublingual Film at American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
Published: 2023-02-21 (Crawled : 13:20) - aquestive.com
AQST | $4.505 14.92% 12.99% 5.8M
|
Health Technology
|
| O: 1.65%
H: 1.03%
C: -3.93%
aqst-109 immunology meeting therapeutics epinephrine positive
Aquestive Therapeutics Announces Positive Decision in States’ Suboxone Antitrust Lawsuit on All Claims
Published: 2022-10-24 (Crawled : 12:20) - aquestive.com
AQST | $4.505 14.92% 12.99% 5.8M
|
Health Technology
|
| O: 3.0%
H: 0.33%
C: -3.98%
therapeutics positive
Aquestive Therapeutics Receives Positive FDA Written Response for AQST-109 Epinephrine Sublingual Film
Published: 2022-10-11 (Crawled : 12:20) - aquestive.com
AQST | $4.505 14.92% 12.99% 5.8M
|
Health Technology
|
| O: 1.96%
H: 8.65%
C: 3.85%
aqst-109 fda therapeutics response epinephrine positive
Aquestive Therapeutics Announces Positive EPIPHAST II Trial Data for AQST-109 When Compared to EpiPen®
Published: 2022-09-27 (Crawled : 12:00) - aquestive.com
AQST | $4.505 14.92% 12.99% 5.8M
|
Health Technology
|
| O: 12.05%
H: 1.2%
C: -9.16%
aqst-109 epipen trial therapeutics positive
Aquestive Therapeutics Reports Positive Initial Topline Data from Part 3 of EPIPHAST Trial Evaluating AQST-109 Epinephrine Oral Film
Published: 2022-06-15 (Crawled : 21:00) - aquestive.com
AQST | $4.505 14.92% 12.99% 5.8M
|
Health Technology
|
| O: -2.74%
H: 4.65%
C: -15.49%
aqst-109 topline trial therapeutics epinephrine positive
Aquestive Therapeutics Reports Positive Topline Data from Part 2 of EPIPHAST Trial Evaluating AQST-109 Epinephrine Oral Film
Published: 2022-04-12 (Crawled : 12:20) - aquestive.com
AQST | $4.505 14.92% 12.99% 5.8M
|
Health Technology
|
| O: -1.85%
H: 6.6%
C: 1.89%
aqst-109 topline therapeutics epinephrine positive
Aquestive Therapeutics Reports Positive Topline Data from Phase 1 Pharmacokinetic Trial of AQST-109 (epinephrine prodrug sublingual film) Supporting its Development as an Oral Alternative to Epinephrine Autoinjectors for the Emergency Treatment of Allergi
Published: 2021-10-25 (Crawled : 13:00) - aquestive.com
AQST | $4.505 14.92% 12.99% 5.8M
|
Health Technology
|
| O: 1.64%
H: 9.45%
C: 7.6%
treatment epinephrine phase 1 positive topline drug trial merge
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.